Trial Profile
Effect of Iloprost inhalation before and during extracorporeal circulation (ECC) on perioperative morbidity and outcome in high risk cardiac surgical patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Dec 2016
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Heart failure; Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms Ilocard
- 16 Nov 2016 Primary endpoint (Duration of post-operative artificial respiration after arrival on intensive care unit) has not been met, according to results presented at the 89th Annual Scientific Sessions of the American Heart Association.
- 16 Nov 2016 Results of this study, presented at the 89th Annual Scientific Sessions of the American Heart Association.
- 07 Jul 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.